Each estimate is based on the consensus of all analysts (approximately 3,500 in total) for 500 companies, weighted by the ...

Zydus Lifesciences is set to acquire Agenus Inc.'s biologics manufacturing facilities in California for $75 million upfront ...

Agenus and Zydus Lifesciences Enter $141M Strategic Collaboration to Advance BOT/BAL, Expand Zydus’ Biologics Manufacturing in the US ...

The move will enable the company to strengthen its foothold in the US and establish its presence in the fast-growing global ...

Since Trump’s re-election in November, the Trump Organization — his family’s real estate empire — has announced 12 new ...

In a two-pronged expansion move, Zydus enters the U.S. biologics CDMO market and secures India-Sri Lanka rights for next-gen ...

Zydus Lifesciences acquires 5.9% stake in Agenus Inc for $16 million, marking entry into the global biologics contract ...

Zydus Lifesciences has acquired a 5.9% stake in U.S.-based Agenus Inc for $16 million, marking its entry into the global ...

Zydus Lifesciences Ltd enters global biologics CDMO market with acquisition of Agenus Inc.'s manufacturing facilities in the ...

Agenus (NASDAQ:AGEN) stock surges 21% after partnering with Zydus Lifesciences for cancer therapies, botensilimab and ...

A live video webcast of the presentation will be available to the general public and can be accessed at ...

A US-based biotech company has successfully sequenced the genetic codes of preserved plants, some of which date back more ...